Tuesday, October 19

Germany and Denmark consider delaying the second dose of Covid vaccine | World News


Germany and Denmark could follow the UK’s plan to delay giving a second dose of the Covid-19 vaccine to people who have already received a first shot, as frustration over the slow progress of European inoculation programs continues. Increasing.

Britain said last week that it would prioritize a first dose of Oxford / AstraZeneca or ,izer / BioNTech to ensure more people were protected earlier, with a second dose 11 or 12, rather than three, weeks later.

While the United States has said it will not follow in the UK’s footsteps, it emerged on Monday that German Health Minister Jens Spahn had asked the country’s disease control agency, the Robert Koch Institute, to investigate the disease. Possibility of postponing a second hit.

The move, which follows widespread criticism that Germany has failed to secure sufficient supplies of the vaccine and has not been able to accelerate its vaccination campaign nationwide, was enthusiastically received by doctors.

Leif Erik Sander, head of the vaccine research team at the Charité hospital in Berlin, said: “In view of the current shortage of vaccines and the very high number of infections and hospitalizations in Germany, a strategy in which the as many people as possible as soon as possible is more effective. ”

Denmark is also looking to widen the gap between hits. The country’s infectious diseases institute said on Monday it would closely monitor the situation in Britain, and that the Health Ministry would be consideFrom an interval of 3-6 weeks.

With the short-term efficacy of the first dose of the ,izer-BioNTech vaccine, the only one to have been approved by the European Medicines Agency so far, estimated to be around 90%, scientists have suggested that a longer gap between the doses might be sensible.


The EMA said in a statement Monday that the maximum interval of 42 days, or six weeks, between doses must be respected. It said that any deviation from this without a change to its marketing authorization would be considered “off-label use,” which means fewer responsibilities for vaccine manufacturers.

In a further attempt to speed up the inoculation process, the German Ministry of Health also recommended that an additional sixth dose be drawn from BioNTech / ,izer jab vials, a practice that has been allowed in several other countries.

While EMA approval for a second injection, from Moderna, expected this week, should ease the situation to some degree, continent-wide vaccine shortages have led to slow roll-out across the continent, generates Increasing frustration.

The EU’s collective vaccine procurement program has come under heavy criticism, with German tabloid Bild criticizing Angela Merkel’s “silence on the vaccine debacle” and demanding that the chancellor explain why a “commissioner was commissioned.” Cypriot EU clearly out of its depth “such a vital job.

Markus Söder, the leader of the Christian Social Union, Merkel’s Bavarian sister party of the CDU, He said on Sunday that the European Commission had “probably planned too bureaucratically: too few of the right vaccines have been ordered and discussions on prices have dragged on for too long.”

BioNTech CEO Uğur Şahin has also said that Europe’s problems were largely the fault of Brussels: the commission had assumed that several different vaccines would be ready at once, so it hadn’t asked for enough doses of BioNtech / ,izer , said.

EU health commissioner Stella Kyriakides has blamed insufficient production capacity, saying the EU has secured 2 billion doses of vaccines for its 450 million citizens from six different manufacturers, but several have yet to eOperationration, while those that have done so are not yet manufactured sufficient volume.

Experts say the shortage should largely end in early spFrom, pointing out that the main factor is how many EU citizens will have been vaccinated in late spFrom or early summer, rather than how many have been vaccinated in early spFrom. from January.

According to Euronews, Denmark has been the most successful EU member state a week after the EU deployment began, with more than 45,800 of the country’s 5.8 million inhabitants receiving a first dose for a vaccination rate of 0, 78 per 100 people.

Germany, with a vaccination rate of 0.23 per 100 people, is next, followed by Croatia, Portugal, Italy and Poland with rates ranging between 0.19 and 0.13. Austria, Bulgaria and Romania are at 0.07, while the Netherlands will not start vaccinating until January 8.

France, meanwhile, is under heavy pressure to accelerate its deliberately cautious vaccination campaign. Emmanuel Macron reportedly met with Prime Minister Jean Castex and Health Minister Olivier Véran on Monday after it emerged that only 516 people were immunized in France last week.

“It’s going too slow,” said epidemiologist Fontanelontanet, noting that 240,000 people were vaccinated in Germany duFrom the same period. Le Monde newspaper asked if France had worn “the European donkey hat”.

The French government has adopted a slow and gradual approach, starting in nursing homes, relying mainly on family doctors to administer the injections and requiFrom prior consultation and written consent, in the face of the most vaccine-skeptical population in Europe.

A survey published on Sunday found that 58% of the French do not want the Covid-19 vaccine, women are more reluctant than men to get vaccinated, and only 32% of the 35-49 age group are happy to receive the vaccine in compared tOver%. over 65 years old.

Experts have said that excessive caution runs the risk of scaFrom as many people as it is reassuFrom. The government has sped up its schedule, vaccinating healthcare workers over 50 starting Monday and saying it will open mass vaccination centers before February.


www.theguardian.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Share